Research Article

The susceptibility of Proteus mirabilis and Enterococcus faecalis to various antimicrobial agents in polymicrobial biofilms formed using a drip flow reactor

Volume: 32 Number: 3 October 31, 2019
EN

The susceptibility of Proteus mirabilis and Enterococcus faecalis to various antimicrobial agents in polymicrobial biofilms formed using a drip flow reactor

Abstract

Objectives: Interspecies interactions in poly-species biofilm are substantial. Our aim is to set up dynamic biofilm models of
Enterococcus faecalis and Proteus mirabilis using Drip Flow Biofilm Reactor (DFR) and to evaluate the effect of these dual population
on anti-biofilms of some antimicrobials.
Materials and Methods: E.faecalis and P.mirabilis biofilms were formed in a DFR. Influences of the dual interactions on their
susceptibilities to antimicrobial agents (disinfectants, antibiotics and probiotic strains) were determined.
Results: Gluteraldehyde and quaternary ammonium compounds (QAC) effectively killed the cells in both biofilms of E.faecalis and
P.mirabilis. However, the efficacy of hydrogen peroxide (H2O2) was dependant on the microbial species present. P. mirabilis was less
susceptible to the ampicillin and ciprofloxacin in co-culture compared to when cultured alone. Here, the influence of the presence
of E.faecalis on P.mirabilis susceptibility was determined. For high concentrations of ciprofloxacin (1024 and 512 μg/ml), the log
reduction in P.mirabilis cells was determined as approximately 4.5 and 3.5 in mono and dual-species biofilms respectively. Compared
to B.lactis, L.acidophilus was found to be more effective both on single and dual species.
Conclusion: The effect of antimicrobial agents on microbial cells in a polymicrobial biofilm may depend on the composition of the
biofilm.

Keywords

References

  1. [1] Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:167-93. doi: 10.1128/Cmr.15.2.167.193.2002
  2. [2] Peeters E, Nelis HJ, Coenye T. Evaluation of the efficacy of disinfection procedures against Burkholderia cenocepacia biofilms. J Hosp Infect 2008;70:361-8. doi: 10.1016/j. jhin.2008.08.015.
  3. [3] Harriott MM, Noverr MC. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob Agents Chemother 2009;53:3914-22. doi: 10.1128/Aac.00657-09.
  4. [4] Armbruster CE, Mobley HLT. Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat Rev Micro 2012;10:743-54. doi: 10.1038/nrmicro2890.
  5. [5] Armbruster CE, Smith SN, Johnson AO, et al. The pathogenic potential of proteus mirabilis is enhanced by other uropathogens during polymicrobial urinary tract ınfection. Infect Immun 2017;85:e00808-16. doi:10.1128/IAI.00808-16.
  6. [6] Armbruster CE, Forsyth-DeOrnellas V, Johnson AO, et al. Genome-wide transposon mutagenesis of Proteus mirabilis: Essential genes, fitness factors for catheter-associated urinary tract infection, and the impact of polymicrobial infection on fitness requirements. PLoS Pathog 2017;13: e1006434. doi: 10.1371/journal.ppat.1006434.
  7. [7] Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcareassociated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 Infect Control Hosp Epidemiol 2008;29:996-1011. doi: 10.1086/591861.
  8. [8] Paganelli FL, Willems RJ and Leavis HL. Optimizing future treatment of enterococcal infections: attacking the biofilm? Trends Microbiol 2012;20:1. doi: 10.1016/j.tim.2011.11.001.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

October 31, 2019

Submission Date

June 30, 2019

Acceptance Date

August 15, 2019

Published in Issue

Year 2019 Volume: 32 Number: 3

APA
Kart, D. (2019). The susceptibility of Proteus mirabilis and Enterococcus faecalis to various antimicrobial agents in polymicrobial biofilms formed using a drip flow reactor. Marmara Medical Journal, 32(3), 137-143. https://doi.org/10.5472/marumj.637153
AMA
1.Kart D. The susceptibility of Proteus mirabilis and Enterococcus faecalis to various antimicrobial agents in polymicrobial biofilms formed using a drip flow reactor. Marmara Med J. 2019;32(3):137-143. doi:10.5472/marumj.637153
Chicago
Kart, Didem. 2019. “The Susceptibility of Proteus Mirabilis and Enterococcus Faecalis to Various Antimicrobial Agents in Polymicrobial Biofilms Formed Using a Drip Flow Reactor”. Marmara Medical Journal 32 (3): 137-43. https://doi.org/10.5472/marumj.637153.
EndNote
Kart D (October 1, 2019) The susceptibility of Proteus mirabilis and Enterococcus faecalis to various antimicrobial agents in polymicrobial biofilms formed using a drip flow reactor. Marmara Medical Journal 32 3 137–143.
IEEE
[1]D. Kart, “The susceptibility of Proteus mirabilis and Enterococcus faecalis to various antimicrobial agents in polymicrobial biofilms formed using a drip flow reactor”, Marmara Med J, vol. 32, no. 3, pp. 137–143, Oct. 2019, doi: 10.5472/marumj.637153.
ISNAD
Kart, Didem. “The Susceptibility of Proteus Mirabilis and Enterococcus Faecalis to Various Antimicrobial Agents in Polymicrobial Biofilms Formed Using a Drip Flow Reactor”. Marmara Medical Journal 32/3 (October 1, 2019): 137-143. https://doi.org/10.5472/marumj.637153.
JAMA
1.Kart D. The susceptibility of Proteus mirabilis and Enterococcus faecalis to various antimicrobial agents in polymicrobial biofilms formed using a drip flow reactor. Marmara Med J. 2019;32:137–143.
MLA
Kart, Didem. “The Susceptibility of Proteus Mirabilis and Enterococcus Faecalis to Various Antimicrobial Agents in Polymicrobial Biofilms Formed Using a Drip Flow Reactor”. Marmara Medical Journal, vol. 32, no. 3, Oct. 2019, pp. 137-43, doi:10.5472/marumj.637153.
Vancouver
1.Didem Kart. The susceptibility of Proteus mirabilis and Enterococcus faecalis to various antimicrobial agents in polymicrobial biofilms formed using a drip flow reactor. Marmara Med J. 2019 Oct. 1;32(3):137-43. doi:10.5472/marumj.637153